Clinical Trials Directory

Trials / Completed

CompletedNCT04366297

Intravascular Access of COVID-19 Patient Under Personal Protective Equipment

Intraosseous Versus Intravenous Access During COVID-19 Patients Performed by Paramedics Wearing Level C Personal Protective Equipment. A Multi-center Prospective Randomized Crossover Single-blinded Simulation Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Lazarski University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The current COVID-19 pandemic, this is especially since the transmission of SARS-CoV-2 is thought to occur mainly through respiratory droplets generated by coughing and sneezing, by direct contact with contaminated surfaces and because in a large number of patients COVID-19 disease may be asymptomatic. As recommended by the CDC medical personnel should be equipped with full personal protective equipment (PPE) for AGP in contact with suspected/confirmed COVID-19 patient. Therefore, it is reasonable to search for the most effective methods of intravascular access in those conditions.

Conditions

Interventions

TypeNameDescription
DEVICEIntravenous accessobtaining intravascular access using a standard intravenous cannula
DEVICEIntraosseous accessobtaining intravascular access using a ready intravenous NIO needle set

Timeline

Start date
2020-01-12
Primary completion
2020-02-25
Completion
2020-02-25
First posted
2020-04-28
Last updated
2020-04-28

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT04366297. Inclusion in this directory is not an endorsement.